Zobrazeno 1 - 10
of 329
pro vyhledávání: '"Carducci, T."'
Autor:
Biagioli, Mario
Publikováno v:
Giornale degli Economisti e Annali di Economia, 1975 Sep 01. 34(9/10), 686-687.
Externí odkaz:
https://www.jstor.org/stable/23242692
Autor:
Heimbach T; Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc., Rahway, New Jersey 07065, United States., Musuamba Tshinanu F; Belgian Federal Agency for Medicines and Health Products, Galileelaan 5/03, Brussels 1210, Belgium., Raines K; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Borges L; ANVISA, SIA Trecho 5 - Guará, Brasília, DF 71205-050, Brazil., Kijima S; Office of New Drug V, Pharmaceuticals and Medical Devices Agency (PMDA), Tokyo 100-0013, Japan., Malamatari M; Medicines & Healthcare Products Regulatory Agency, 10 S Colonnade, London SW1W 9SZ, U.K., Moody R; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Veerasingham S; Pharmaceutical Drugs Directorate (PDD), Health Canada, 1600 Scott St, Ottawa, Ontario K1A 0K9, Canada., Seo P; Office of Clinical Pharmacology (OCP), Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Turner D; Certara Predictive Technologies, Level 2-Acero, Simcyp Ltd, 1 Concourse Way, Sheffield S1 2BJ, United Kingdom., Fang L; Division of Quantitative Methods and Modeling (DQMM), Office of Research and Standards (ORS), Office of Generic Drugs (OGD), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Stillhart C; Pharmaceutical R&D, F. Hoffmann-La Roche Ltd., Basel CH-4070, Switzerland., Bransford P; Data and Computational Sciences, Vertex Pharmaceuticals, Inc., Boston, Massachusetts 02210, United States., Ren X; PK Sciences/Translational Medicine, BioMedical Research, Novartis, One Health Plaza, East Hanover, New Jersey 07936, United States., Patel N; Certara Predictive Technologies, Level 2-Acero, Simcyp Ltd, 1 Concourse Way, Sheffield S1 2BJ, United Kingdom., Sperry D; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, United States., Chen H; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Rostami-Hodjegan A; Certara Predictive Technologies, Level 2-Acero, Simcyp Ltd, 1 Concourse Way, Sheffield S1 2BJ, United Kingdom.; Centre for Applied Pharmacokinetic Research, University of Manchester, Stopford Building, Oxford Road, Manchester M139PT, U.K., Lukacova V; Simulations Plus Inc., 42505 10th Street West, Lancaster, California 93534, United States., Sun D; The University of Michigan, North Campus Research Complex (NCRC), 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States., Nguefack JF; Head of Biopharmacy Team, Montpellier, Synthetics Platform, Global CMC, Sanofi, Paris 75008, France., Carducci T; Analytical Commercialization Technology, Merck & Co., Inc., 126 E. Lincoln Ave, Rahway, New Jersey 07065, United States., Grimstein M; Office of Clinical Pharmacology (OCP), Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Pepin X; Simulations Plus Inc., 42505 10th Street West, Lancaster, California 93534, United States., Jamei M; Certara Predictive Technologies, Level 2-Acero, Simcyp Ltd, 1 Concourse Way, Sheffield S1 2BJ, United Kingdom., Stamatopoulos K; Biopharmaceutics, DPD, MDS, GlaxoSmithKline, David Jack Centre, Park Road, Ware SG12 0DP, U.K., Li M; Office of Clinical Pharmacology (OCP), Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Sanghavi M; Certara Predictive Technologies, Level 2-Acero, Simcyp Ltd, 1 Concourse Way, Sheffield S1 2BJ, United Kingdom., Tannergren C; Biopharmaceutics Science, New Modalities & Parenteral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg 43183, Sweden., Mandula H; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Zhao Z; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Ju TR; Analytical R&D, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States., Wagner C; Global Drug Product Development, Global CMC Development, the Healthcare Business of Merck KGaA, Darmstadt 64293, Germany., Arora S; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Wang M; Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc., Rahway, New Jersey 07065, United States., Rullo G; Regulatory CMC, AstraZeneca, 1 Medimmune Way, Gaithersburg, Maryland 20878, United States., Mitra A; Clinical Pharmacology, Kura Oncology Inc, Boston, Massachusetts 02210, United States., Kollipara S; Biopharmaceutics Group, Global Clinical Management, Integrated Product Development Organization (IPDO), Dr. Reddy's Laboratories Ltd., Bachupally, Medchal Malkajgiri District, Hyderabad, 500 090 Telangana, India., Chirumamilla SK; Certara Predictive Technologies, Level 2-Acero, Simcyp Ltd, 1 Concourse Way, Sheffield S1 2BJ, United Kingdom., Polli JE; School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, United States., Mackie C; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2024 Nov 04; Vol. 21 (11), pp. 5353-5372. Date of Electronic Publication: 2024 Sep 30.
Autor:
Pepin X; Regulatory Affairs, Simulations Plus Inc., 42505 10th Street West, Lancaster, California 93534-7059, United States., Arora S; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Borges L; ANVISA, SIA Trecho 5́, Guara, Brasília, Federal District 71205-050, Brazil., Cano-Vega M; Drug Product Technologies, Amgen Inc., Thousand Oaks, California 91320-1799, United States., Carducci T; Analytical Commercialization Technology, Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, New Jersey 07065, United States., Chatterjee P; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Chen G; Takeda Development Center Americas Inc., 300 Shire Way, Lexington, Massachusetts 02421, United States., Cristofoletti R; College of Pharmacy, University of Florida, 6550 Sanger Rd., Orlando, Florida 32827, United States., Dallmann A; Bayer HealthCare SAS, 59000 Lille, France, on behalf of Bayer AG, Pharmacometrics/Modeling and Simulation, Systems Pharmacology & Medicine, PBPK, Leverkusen, Germany., Delvadia P; Office of Translational Science, Office of Clinical Pharmacology (OCP), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Dressman J; Fraunhofer Institute of Translational Medicine and Pharmacology, Frankfurt am Main 60596, Germany., Fotaki N; University of Bath, Claverton Down, Bath BA2 7AY, United Kingdom., Gray E; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Heimbach T; Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc., Rahway, New Jersey 07065, United States., Holte Ø; Norwegian Medical Products Agency, Oslo 0213, Norway., Kijima S; Office of New Drug V, Pharmaceuticals and Medical Devices Agency (PMDA), Tokyo 100-0013, Japan., Kotzagiorgis E; European Medicines Agency (EMA), Domenico Scarlattilaan 6, Amsterdam 1083 HS, The Netherlands., Lennernäs H; Translational Drug Discovery and Development, Department of Pharmaceutical Bioscience, Uppsala University, Uppsala 751 05, Sweden., Lindahl A; Swedish Medical Products Agency, Uppsala 752 37, Sweden., Loebenberg R; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmontonton T6G 2E1, Canada., Mackie C; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Malamatari M; Medicines & Healthcare Products Regulatory Agency, 10 S Colonnade, London SW1W 9SZ, United Kingdom., McAllister M; Global Biopharmaceutics, Drug Product Design, Pfizer, Sandwich CT13 9NJ, United Kingdom., Mitra A; Clinical Pharmacology, Kura Oncology Inc., Boston, Massachusetts 02210, United States., Moody R; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Mudie D; Global Research and Development, Small Molecules, Lonza, 63045 NE Corporate Pl., Bend, Oregon 97701, United States., Musuamba Tshinanu F; Belgian Federal Agency for Medicines and Health Products, Galileelaan 5/03, Brussel 1210, Belgium., Polli JE; School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, United States., Rege B; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Ren X; PK Sciences/Translational Medicine, BioMedical Research, Novartis, One Health Plaza, East Hanover, New Jersey 07936, United States., Rullo G; Regulatory CMC, AstraZeneca, 1 Medimmune Way, Gaithersburg, Maryland 20878, United States., Scherholz M; Pharmaceutical Development, Bristol Myers Squibb, Route 206 & Province Line Road, Princeton, New Jersey 08543, United States., Song I; Takeda Development Center Americas Inc., 300 Shire Way, Lexington, Massachusetts 02421, United States., Stillhart C; Pharmaceutical R&D, F. Hoffmann-La Roche Ltd., Basel 4070, Switzerland., Suarez-Sharp S; Regulatory Affairs, Simulations Plus Inc., 42505 10th Street West, Lancaster, California 93534-7059, United States., Tannergren C; Biopharmaceutics Science, New Modalities & Parenteral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg 431 50, Sweden., Tsakalozou E; Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20903-1058, United States., Veerasingham S; Pharmaceutical Drugs Directorate (PDD), Health Canada, 1600 Scott St., Ottawa K1A 0K9, Canada., Wagner C; Global Drug Product Development, Global CMC Development, the Healthcare Business of Merck KGaA, Darmstadt D-64293, Germany., Seo P; Office of Translational Science, Office of Clinical Pharmacology (OCP), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2024 Aug 05; Vol. 21 (8), pp. 3697-3731. Date of Electronic Publication: 2024 Jun 30.
Autor:
ATLAS Collaboration (AUTHOR), Aad, G.1 (AUTHOR), Aakvaag, E.2 (AUTHOR), Abbott, B.3 (AUTHOR), Abeling, K.4 (AUTHOR), Abicht, N. J.5 (AUTHOR), Abidi, S. H.6 (AUTHOR), Aboelela, M.7 (AUTHOR), Aboulhorma, A.8 (AUTHOR), Abramowicz, H.9 (AUTHOR), Abreu, H.10 (AUTHOR), Abulaiti, Y.11 (AUTHOR), Acharya, B. S.12,13,14 (AUTHOR), Ackermann, A.15 (AUTHOR), Bourdarios, C. Adam16 (AUTHOR), Adamczyk, L.17 (AUTHOR), Addepalli, S. V.18 (AUTHOR), Addison, M. J.19 (AUTHOR), Adelman, J.20 (AUTHOR), Adiguzel, A.21 (AUTHOR)
Publikováno v:
European Physical Journal C -- Particles & Fields. Oct2024, Vol. 84 Issue 10, p1-34. 34p.
Autor:
Alcucci, E., Gori, S, ., Berti, D., Brutto, F., Carducci, T., Cefalì, A, Chiarini, E., Crosetto, S., Cultrera, F., Marcantonio, P., Durante, F., Evangelista, P., Fubelli, G., Giaccio, B, ., Lancia, M, ., Liberi, F, ., Sardo, L, ., Madonna, Mondati, G, ., Moro, M., Napoli, G., Pavano, F., Saroli, Michele, Silvestri, Sposato, A., Tinelli, F, Trotta, D.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3980::e2bfcaa1b5c2c128eefc839967e222a6
http://hdl.handle.net/11580/57794
http://hdl.handle.net/11580/57794
Autor:
Aad, G.1 (AUTHOR), Aakvaag, E.2 (AUTHOR), Abbott, B.3 (AUTHOR), Abdelhameed, S.4 (AUTHOR), Abeling, K.5 (AUTHOR), Abicht, N. J.6 (AUTHOR), Abidi, S. H.7 (AUTHOR), Aboelela, M.8 (AUTHOR), Aboulhorma, A.9 (AUTHOR), Abramowicz, H.10 (AUTHOR), Abreu, H.11 (AUTHOR), Abulaiti, Y.12 (AUTHOR), Acharya, B. S.13,14,15 (AUTHOR), Ackermann, A.16 (AUTHOR), Bourdarios, C. Adam17 (AUTHOR), Adamczyk, L.18 (AUTHOR), Addepalli, S. V.19 (AUTHOR), Addison, M. J.20 (AUTHOR), Adelman, J.21 (AUTHOR), Adiguzel, A.22 (AUTHOR)
Publikováno v:
European Physical Journal C -- Particles & Fields. Sep2024, Vol. 84 Issue 9, p1-40. 40p.
Autor:
Taddei, A, Dalmiani, S, Vellani, A, Rocca, E, Piccini, G, Carducci, T, Gori, A, Borghini, R, Marcheschi, P, Mazzarisi, A, Salvatori, C, Macerata, ALBERTO MARCO MARIA, Varanini, Maurizio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3728::249c1adb667747391cfde571be511774
http://hdl.handle.net/11568/126676
http://hdl.handle.net/11568/126676
Autor:
Taddei, A., Gori, A., Rocca, E., Carducci, T., Piccini, G., Augiero, G., Festa, P., Assanta, N., Ricci, G., Murzi, B.
Publikováno v:
International Conference on Health Informatics; 2014, p268-271, 4p
Autor:
Gori, A., Taddei, A., Mota, D., Rocca, E., Carducci, T., Piccini, G., Ciregia, A., Marcheschi, P., Assanta, N., Murzi, B., Ricci, G.
Publikováno v:
Computing in Cardiology, 2010; 2010, p481-484, 4p